Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) dropped 3.6% during mid-day trading on Monday . The stock traded as low as $14.78 and last traded at $14.79. Approximately 55,852 shares changed hands during trading, a decline of 89% from the average daily volume of 530,911 shares. The stock had previously closed at $15.34. Analysts […]
Deciphera Pharmaceuticals (NASDAQ:DCPH) Given New $23 00 Price Target at Stifel Nicolaus theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) was upgraded by equities researchers at Jonestrading from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, Benzinga reports. A number of other equities analysts have also issued reports on DCPH. Stifel Nicolaus upgraded shares of Deciphera Pharmaceuticals from a “hold” rating […]
Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) had its target price increased by Stifel Nicolaus from $20.00 to $22.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 88.68% from the company’s current price. DCPH has […]
Research Analysts Offer Predictions for Deciphera Pharmaceuticals, Inc s Q3 2023 Earnings (NASDAQ:DCPH) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.